Lapathoside A
CAS No. 373646-49-2
Lapathoside A ( )
Catalog No. M32666 CAS No. 373646-49-2
Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 628 | In Stock |
|
50MG | Get Quote | In Stock |
|
100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameLapathoside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionLapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
DescriptionLapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number373646-49-2
-
Formula Weight986.9
-
Molecular FormulaC50H50O21
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SSD114 hydrochloride
SSD114 is a novel GABAB receptor positive allosteric modulator.
-
AI-10-47
AI-10-47 is a small molecule inhibitor of CBFβ-RUNX binding(IC50 : 3.2 μM).
-
Neolancerin
Neolancerin is a natural product isolated from adventitious roots of St. John’s wort (Hypericum perforatum L.).